Thirteenth edition highlights ever-increasing threat to cyber security and data protection
We have released our 2017 Annual Litigation Trends Survey. This year’s survey polled more than 300 senior corporate counsel representing US-based organizations on disputes-related issues and concerns.
Survey respondents point to a growing threat to cyber security, an issue they indicate stands as the greatest emerging threat to a business. Nearly two-thirds of those polled (63 percent) feel more exposed to disputes in this area.
This year’s survey report also revisits its litigation minimization framework, a tool introduced last year to suit a company’s specific situation. In-house counsel can use this framework to review their current approach and implement measures to reduce litigation risk and costs. The program was well-received in its first year, with 95 percent of respondents implementing at least one recommended key measure. Training emerges as the leading factor in preventing litigation. Early case resolution, embedding lawyers in the business and proactive contract review have also shown to be highly effective.
Publication
Africa faces a stark reality: contributing less than 4% of global greenhouse gas emissions, the continent is disproportionately impacted by climate change, threatening its development and stability.
Publication
Facing the fast-growing development of AI across the globe, particularly Generative AI (GenAI), the G7 competition authorities and policymakers (Canada, France, Germany, Japan, Italy, the UK and the US) and the European Commission met in Italy on 3-4 October 2024 to discuss the main competition challenges raised by these new technologies in digital markets.
Publication
Miranda Cole, Julien Haverals and Emma Clarke of our Brussels/ London offices are the authors of a chapter on procedural issues in merger control that has been published in the third edition of the Global Competition Review’s The Guide to Life Sciences. This covers a number of significant procedural developments that have affected merger review of life sciences transactions.
Subscribe and stay up to date with the latest legal news, information and events . . .
© Norton Rose Fulbright LLP 2023